Answers are grounded in this paper and cite their sources.
Multicenter clinical trial demonstrates high occlusion rates with low adverse events for the Pipeline device in large intracranial aneurysms, indicating a safe treatment option.
PED offers a reasonably safe and effective treatment of large or giant intracranial internal carotid artery aneurysms, demonstrated by high rates of complete aneurysm occlusion and low rates of adverse neurologic events; even in aneurysms failing previous alternative treatments.
No takes yet. Share an insight, caveat, or question.
Becske et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: